NO308657B1 - 4-hydroksy-piperidinderivater - Google Patents

4-hydroksy-piperidinderivater

Info

Publication number
NO308657B1
NO308657B1 NO973337A NO973337A NO308657B1 NO 308657 B1 NO308657 B1 NO 308657B1 NO 973337 A NO973337 A NO 973337A NO 973337 A NO973337 A NO 973337A NO 308657 B1 NO308657 B1 NO 308657B1
Authority
NO
Norway
Prior art keywords
piperidine
hydroxy
Prior art date
Application number
NO973337A
Other languages
English (en)
Norwegian (no)
Other versions
NO973337L (no
NO973337D0 (no
Inventor
Alexander Alanine
Bernd Buettelmann
Marie-Paule Heitz Neidhart
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO973337D0 publication Critical patent/NO973337D0/no
Publication of NO973337L publication Critical patent/NO973337L/no
Publication of NO308657B1 publication Critical patent/NO308657B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO973337A 1996-07-19 1997-07-18 4-hydroksy-piperidinderivater NO308657B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96111660 1996-07-19
EP97105366 1997-04-01

Publications (3)

Publication Number Publication Date
NO973337D0 NO973337D0 (no) 1997-07-18
NO973337L NO973337L (no) 1998-01-20
NO308657B1 true NO308657B1 (no) 2000-10-09

Family

ID=26142078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973337A NO308657B1 (no) 1996-07-19 1997-07-18 4-hydroksy-piperidinderivater

Country Status (34)

Country Link
US (1) US5889026A (fr)
EP (1) EP0824098B1 (fr)
JP (1) JP3179050B2 (fr)
KR (1) KR100235804B1 (fr)
CN (1) CN1120154C (fr)
AR (2) AR007898A1 (fr)
AT (1) ATE207899T1 (fr)
AU (1) AU719352B2 (fr)
BR (1) BR9704031A (fr)
CA (1) CA2210044C (fr)
CO (1) CO4900064A1 (fr)
CZ (1) CZ290898B6 (fr)
DE (1) DE69707782T2 (fr)
DK (1) DK0824098T3 (fr)
ES (1) ES2164967T3 (fr)
HK (1) HK1009124A1 (fr)
HR (1) HRP970394A2 (fr)
HU (1) HUP9701194A3 (fr)
ID (1) ID19632A (fr)
IL (1) IL121299A (fr)
MA (1) MA24274A1 (fr)
MX (1) MX9705387A (fr)
NO (1) NO308657B1 (fr)
NZ (1) NZ328330A (fr)
PE (1) PE86398A1 (fr)
PL (1) PL321201A1 (fr)
PT (1) PT824098E (fr)
RU (1) RU2178412C2 (fr)
SG (1) SG60085A1 (fr)
TR (1) TR199700659A2 (fr)
TW (1) TW498067B (fr)
UY (1) UY24625A1 (fr)
YU (1) YU30197A (fr)
ZA (1) ZA976224B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
DZ2805A1 (fr) * 1998-06-02 2005-01-30 Cadus Pharmaceutical Corp Composition à pyrroloÄ2,,3dÜ pyrimidine et leurs usages.
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina
DE69938193D1 (de) 1998-11-20 2008-04-03 Hoffmann La Roche Piperidin ccr-3 rezeptor-hemmer
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6432985B2 (en) * 2000-04-25 2002-08-13 Hoffmann-La Roche Inc. Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists
US6407235B1 (en) 2000-08-21 2002-06-18 Hoffmann-La Roche Inc. Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol
EP1674087A1 (fr) 2000-10-02 2006-06-28 Pfizer Products Inc. Utilisation prophylactique d'antagonistes des récepteurs du N-méthyl-D-aspartate (NMDA)
US6680324B2 (en) * 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
AU2002250256B2 (en) * 2001-03-08 2008-04-03 Emory University pH-dependent NMDA receptor antagonists
IL159393A (en) 2001-07-24 2011-01-31 Richter Gedeon Vegyeszet Piperidine derivatives, pharmaceutical compositions containing them, processes for their preparation and uses thereof
CA2468673C (fr) * 2001-11-30 2011-01-25 Osi Pharmaceuticals, Inc. Composes specifiques inhibant les recepteurs a1 et a3 de l'adenosine, et applications desdits composes
EA007468B1 (ru) * 2001-12-20 2006-10-27 Оси Фармасьютикалз, Инк. Пиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
WO2005030720A1 (fr) * 2003-09-25 2005-04-07 Shionogi & Co., Ltd. Derive de piperidine presentant une activite antagoniste du recepteur ndma
EP1680127B1 (fr) * 2003-10-23 2008-10-15 F. Hoffmann-La Roche Ag Derives de benzazepine utiles comme inhibiteurs de mao-b
HUP0401522A2 (en) * 2004-07-29 2006-04-28 Richter Gedeon Vegyeszet New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
US7485637B2 (en) * 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
MX2009014216A (es) * 2007-06-29 2010-07-05 Univ Emory Antagonistas del receptor nmda para neuroproteccion.
US7869022B2 (en) 2007-07-18 2011-01-11 Asml Netherlands B.V. Inspection method and apparatus lithographic apparatus, lithographic processing cell, device manufacturing method and distance measuring system
CA2722776A1 (fr) * 2008-05-09 2009-11-12 Emory University Antagonistes des recepteurs nmda utilisables pour le traitement de troubles neuropsychiatriques
US7874106B2 (en) * 2009-02-13 2011-01-25 Ykk Corporation Of America Sill flashing and end dam assembly
MX368459B (es) * 2009-10-19 2019-10-03 Amicus Therapeutics Inc Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
HUE028129T2 (en) * 2009-10-19 2016-11-28 Amicus Therapeutics Inc New preparations for the prevention and / or treatment of lysosomal storage disorders
WO2016100823A1 (fr) 2014-12-19 2016-06-23 The Broad Institute, Inc. Ligands du récepteur d2 de la dopamine
EP3233077A4 (fr) 2014-12-19 2018-08-08 The Broad Institute Inc. Ligands des récepteurs dopaminergiques d2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222726B1 (hu) * 1990-02-06 2003-09-29 Pfizer, Inc., Piperidinszármazékok, eljárás elżállításukra és az ezeket tartalmazó gyógyszerkészítmények
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
TW281670B (fr) * 1993-09-02 1996-07-21 Hoffmann La Roche
PL179448B1 (pl) * 1994-01-31 2000-09-29 Pfizer Neuroochronne zwiazki chromanoloweoraz kompozycje farmaceutyczne zawierajace te zwiazki PL PL PL PL PL
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists

Also Published As

Publication number Publication date
AU719352B2 (en) 2000-05-04
TW498067B (en) 2002-08-11
NO973337L (no) 1998-01-20
TR199700659A2 (xx) 1998-02-21
EP0824098A1 (fr) 1998-02-18
CZ290898B6 (cs) 2002-11-13
AR007897A1 (es) 1999-11-24
KR980009244A (ko) 1998-04-30
ID19632A (id) 1998-07-23
RU2178412C2 (ru) 2002-01-20
CZ227497A3 (cs) 1998-02-18
SG60085A1 (en) 1999-02-22
HK1009124A1 (en) 1999-05-28
PE86398A1 (es) 1998-12-10
DK0824098T3 (da) 2002-02-18
YU30197A (sh) 1999-12-27
CO4900064A1 (es) 2000-03-27
MX9705387A (es) 1998-01-31
NO973337D0 (no) 1997-07-18
US5889026A (en) 1999-03-30
HUP9701194A3 (en) 1999-06-28
JPH1067742A (ja) 1998-03-10
NZ328330A (en) 1998-05-27
HUP9701194A2 (hu) 1999-05-28
EP0824098B1 (fr) 2001-10-31
AU2875697A (en) 1998-01-29
CN1120154C (zh) 2003-09-03
UY24625A1 (es) 2000-12-29
CA2210044A1 (fr) 1998-01-19
KR100235804B1 (ko) 1999-12-15
CN1171396A (zh) 1998-01-28
JP3179050B2 (ja) 2001-06-25
HRP970394A2 (en) 1998-06-30
IL121299A0 (en) 1998-01-04
PT824098E (pt) 2002-04-29
AR007898A1 (es) 1999-11-24
DE69707782D1 (de) 2001-12-06
CA2210044C (fr) 2006-02-14
ES2164967T3 (es) 2002-03-01
HU9701194D0 (en) 1997-09-29
IL121299A (en) 2001-12-23
DE69707782T2 (de) 2002-06-20
ATE207899T1 (de) 2001-11-15
PL321201A1 (en) 1998-02-02
MA24274A1 (fr) 1998-04-01
ZA976224B (en) 1998-01-19
BR9704031A (pt) 1998-12-29

Similar Documents

Publication Publication Date Title
DK0824098T3 (da) 4-Hydroxy-piperidinderivater
ID19474A (id) Turunan tiazola
ID18095A (id) Turunan tetrahidrokinolin
DE69722935T2 (de) Hintergauge
NO975541D0 (no) 4-hydroksy-piperidinderivater
ID17945A (id) Lemari es
FR2743439B1 (fr) Enseigne
FI965275A0 (fi) Aonglaoda i kartong- eller pappersmaskin
KR980000937U (ko) 팽이
ITMT960002U1 (it) D e d
KR970050198U (ko) 개량감지기
FI2674U1 (fi) Långnyppress i en pappers- eller kartongmaskin
FI2555U1 (fi) Konttikannatin
FI964372A0 (fi) Flyttbar kontainerlaos i jaernvaegsvagn
FI960733A0 (fi) Anordning i en kontaktskena
FI964007A0 (fi) Styrsystem foer ventiler i en foerbraenningsmotor
FI964603A0 (fi) Vaermefogningsstoedstomme i silikon-gummi foer en ankelsockas skaftdel
FI963563A0 (fi) Taetningsarrangemang i en fibersbanas torkningsanordning
FI964279A0 (fi) Foerfarande foer avlaegsna torsionspaenning i textilgarn
FI964904A0 (fi) Tryckknapp i hissen
FI964979A0 (fi) Stoedvagga foer bestrykningsstav i pappersbanebestrykningsanordning
FI963104A0 (fi) Basskontroll i en hemteateranordning
FI963961A0 (fi) Saekerhetsanordning i vaegtrafiken
FI960287A0 (fi) Anordning i avdammningsanlaeggning
FI965276A0 (fi) Aonglaoda i kartong- eller pappersmaskin